The LEVF and Dr. Aubrey de Grey are advancing effective treatments to combat human age-related disease.

Dr. Aubrey de Grey — President and Chief Science Officer of the Longevity Escape Velocity Foundation
Dr. Aubrey de Grey (Ph.D.) — President and Chief Science Officer of the Longevity Escape Velocity Foundation.

Dr. Aubrey de Grey, Ph.D., is President & Chief Science Officer of the Longevity Escape Velocity (LEV) Foundation (https://www.levf.org/), an organization focused on proactively identifying and addressing the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease.

Dr. de Grey has been recognized internationally as a visionary and biomedical gerontologist. He developed the Strategies for Engineered Negligible Senescence, which is a set of comprehensive methods that rejuvenates the body to prevent age-related illnesses and mortality. He co-founded several non-profit organisations, including Methuselah Foundation and SENS Research Foundation. The LEV Foundation was founded to accelerate the development of this technology.

Dr. de Grey earned his Bachelor of Science in Computer Science in 1985, and a Ph.D. degree in Biology in 2000 from the University of Cambridge. He is the co-author of Ending Aging (2007), The Mitochondrial Free Radical Theory of Aging, (1999), and many academic papers.

Dr. de Grey has been a Fellow of the Gerontological Society of America as well as the American Aging Association. He also sits on advisory boards of many scientific journals and organizations. He is an accomplished speaker and regularly speaks at conferences around the world.

Source:

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注